Webinar Invitation: Biomarker Commercialization - Introduction to European IVD Regulation - August 26, 2020, at 13:00-14:30 CET

Submitted by TSCP on 10 August 2020

Welcome to our second webinar on How to Commercialize your Biomarker Discovery

- a free webinar series focusing on biomarker commercialization process.

Focus of this second webinar is on European IVD Regulation with a speaker from the Finnish Medicines Agency FIMEA.

This webinar dives into the regulatory requirements for biomarker development and commercialization, an important know-how for any research group, SME or TTO working with biomarker development.

The IVD regulation is also covered in detail in the Biomarker Commercialization (BIC) toolset, designed to support, step-by-step, both academic researchers and SMEs when developing a biomarker-based invention to a commercial product. The BIC toolset includes a Biomarker Commercialization Guide, which covers technical, clinical, commercial and regulatory aspects, a Best Practices Handbook based on experiences from TTOs in the field, and a review tool for TTOs and a Guide for Regulatory Process. The toolset has been created in the BIC project funded by Interreg Baltic Sea Region Programme, and it will be available for free in summer 2020.

The webinar is taking place on August 26, 2020, at 13:00-14:30 CET.

Webinar programme:

13:00-14:00 CET                   Introduction to European IVD regulation – requirements for biomarker product development and commercialization

Nelli Karhu, Finnish Medicines Agency FIMEA

14:00-14:30 CET                   Q&A  

Moderator: Teppo Laaksonen, Network Manager, Turku Science Park Ltd

Please register here: https://attendee.gotowebinar.com/register/1289214075214936335

Best Regards,

BIC Biomarker Commercialization project team

https://biomarker.nu/

Cluster organisation
HealthTurku
Share this Article